These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7688403)

  • 21. Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions.
    Mori M; Pimpinelli N; Romagnoli P; Bernacchi E; Fabbri P; Giannotti B
    Histopathology; 1994 Apr; 24(4):311-21. PubMed ID: 8045520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between recurrence and expression of proliferating cell nuclear antigen, sialyl LewisX, and sialyl Lewis(a) in lung cancer.
    Ogawa J; Sano A; Koide S; Shohtsu A
    J Thorac Cardiovasc Surg; 1994 Aug; 108(2):329-36. PubMed ID: 7913734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased numbers of CD68 antigen positive dendritic epidermal cells and upregulation of CLA (cutaneous lymphocyte-associated antigen) expression on these cells in various skin diseases.
    Nakamura K; Yasaka N; Asahina A; Kato M; Miyazono K; Furue M; Tamaki K
    J Dermatol Sci; 1998 Dec; 18(3):170-80. PubMed ID: 9865449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous colloidal gold immunoelectronmicroscopy labeling of CD1a, HLA-DR, and CD4 surface antigens of human epidermal Langerhans cells.
    De Panfilis G; Manara GC; Ferrari C; Torresani C
    J Invest Dermatol; 1988 Dec; 91(6):547-52. PubMed ID: 3263998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells.
    Peiser M; Grützkau A; Wanner R; Kolde G
    J Immunol Methods; 2003 Aug; 279(1-2):41-53. PubMed ID: 12969546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells.
    Ohmori K; Takada A; Ohwaki I; Takahashi N; Furukawa Y; Maeda M; Kiso M; Hasegawa A; Kannagi M; Kannagi R
    Blood; 1993 Nov; 82(9):2797-805. PubMed ID: 7693048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Despite the presence of UVB-induced DNA damage, HLA-DR+ cells from ex vivo UVB-exposed human skin are able to migrate and show no impaired allostimulatory capacity.
    Kremer IB; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Invest Dermatol; 1997 Nov; 109(5):626-31. PubMed ID: 9347789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Langerhans' cells and lymphocytic infiltrate in AIDS-associated Kaposi's sarcoma. An immunohistochemical study.
    Valcuende-Cavero F; Febrer-Bosch MI; Castells-Rodellas A
    Acta Derm Venereol; 1994 May; 74(3):183-7. PubMed ID: 7521102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells.
    Davis AL; McKenzie JL; Hart DN
    Immunology; 1988 Dec; 65(4):573-81. PubMed ID: 3065220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solar-simulating irradiation of the skin of human subjects in vivo produces Langerhans cell responses distinct from irradiation ex vivo and in vitro.
    Laihia JK; Jansen CT
    Exp Dermatol; 2000 Aug; 9(4):240-7. PubMed ID: 10949544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterisation of two human dendritic cell-lines that express CD1a, take-up, process and present soluble antigens and induce MLR.
    Nunez R; Sanchez M; Wild P; Filgueira L; Nunez C
    Immunol Lett; 1998 Mar; 61(1):33-43. PubMed ID: 9562373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of Langerhans cell protein kinase C-beta isoenzyme expression in inflammatory and hyperplastic dermatoses.
    Reynolds NJ; Yi JY; Fisher GJ; Cooper KD; Voorhees JJ; Griffiths CE
    Br J Dermatol; 1995 Aug; 133(2):157-67. PubMed ID: 7547380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DMC1: a monoclonal antibody produced from histiocytosis X cells which reacts with the native CD1a molecule of human epidermal Langerhans cells.
    Dezutter-Dambuyant C; Schmitt D; Staquet MJ; Gaucherand M; Cambazard F; Thivolet J
    Hybridoma; 1989 Apr; 8(2):199-208. PubMed ID: 2469637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of granulocyte macrophage-colony stimulating factor on Langerhans cells in normal and healthy atopic subjects.
    Smith CH; Allen MH; Groves RW; Barker JN
    Br J Dermatol; 1998 Aug; 139(2):239-46. PubMed ID: 9767237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Internalization of surface HLA-DR molecules by human epidermal Langerhans cells: analysis by flow cytometry and confocal microscopy.
    Rizova H; Carayon P; Michel L; Barbier A; Lacheretz F; Dubertret L
    Cell Biol Toxicol; 1994 Dec; 10(5-6):367-73. PubMed ID: 7697498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.
    Meunier L; Vian L; Lagoueyte C; Lavabre-Bertrand T; Duperray C; Meynadier J; Cano JP
    Cytometry; 1996 Dec; 26(4):260-4. PubMed ID: 8979024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation.
    Volc-Platzer B; Rappersberger K; Mosberger I; Hinterberger W; Emminger-Schmidmeier W; Radaszkiewicz T; Wolff K
    J Invest Dermatol; 1988 Aug; 91(2):162-8. PubMed ID: 3294303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ICAM-3/LFA-1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells.
    Griffiths CE; Railan D; Gallatin WM; Cooper KD
    Br J Dermatol; 1995 Dec; 133(6):823-9. PubMed ID: 8547030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.